Article
ADAMTS-13 activity and ischemic heart disease: a Mendelian randomization study.
Journal of thrombosis and haemostasis : JTH - 1 Nov 2018
Schooling C M, Luo S, Johnson G
Abstract excerpt
Essentials Cardiovascular disease remains the leading cause of global mortality despite progress in control. We assessed the role of ADAMTS-13 in ischemic heart disease using Mendelian randomization. Genetically instrumented ADAMTS-13 activity reduced ischemic heart disease. Therapeutics targeting ADAMTS-13 activity could perhaps be repurposed in ischemic heart disease. BACKGROUND: Despite great progress in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
